Scope
Reference
CLI-FTS-58614
Description
This is a national framework for the provision of Insulin Pumps, Continuous Glucose Monitors (CGM), associated diabetes consumables and tech. The framework will be managed by NHS Wales Shared Services Partnership Procurement Services (hosted by the Velindre NHS Trust) "NWSSP" on behalf of the following Organisations, who shall enter into the Agreement: Aneurin Bevan University Health Board, Betsi Cadwaladr University Health Board, Cardiff & Vale University Health Board, Cwm Taf Morgannwg University Health Board, Hywel Dda University Health Board, and Swansea Bay University Health Board. The framework will provide nationally contracted pricing and enable NHS Wales to harness improved pricing should Participating Organisations look to utilise commercial offers levied by framework suppliers. Bidders should note that the requirement for Lot 2 (CGM) is for procured product (not prescribed) i.e. the product can be procured and prescribed but it must be available via the procured route. This framework will only manage procured CGM. In respect of Lot 5 "Smart Insulin Pens" these must be available via the procured route and include technology. The framework will only manage procured smart insulin pens. NHS Wales will accept bids in respect of technology used in automated insulin delivery systems such as hybrid closed looping as well as stand alone technology (eg. a CGM which does not align with HCL).
Commercial tool
Establishes a framework
Total value (estimated)
- £88,280,976 excluding VAT
- £105,937,171 including VAT
Above the relevant threshold
Main procurement category
Goods
CPV classifications
- 33000000 - Medical equipments, pharmaceuticals and personal care products
Lot constraints
Description of how multiple lots may be awarded:
There is no limitation on the number of lots a supplier can bid for. Each Lot will be evaluated separately. The criteria applicable to each lot is included in the ITT document.
Not the same for all lots
Contract locations and contract dates are shown in Lot sections, because they are not the same for all lots.
Lot 1. Tubed Insulin Pumps
Description
Tubed Insulin Pumps and their associated consumables.
Lot value (estimated)
- £7,200,000 excluding VAT
- £8,640,000 including VAT
Framework lot values may be shared with other lots
Contract dates (estimated)
- 1 February 2026 to 31 January 2029
- Possible extension to 31 January 2030
- 4 years
Description of possible extension:
There is an optional 12 month extension. The procurement lead will engage with clinical stakeholders from participating Organisations to determine if the extension option should be utilised. Approval to extend would be sought in line with established NWSSP governance processes.
Same for all lots
CPV classifications are shown in the Scope section, because they are the same for all lots.
Lot 2. CGM
Description
Procured CGM
Lot value (estimated)
- £7,200,000 excluding VAT
- £8,640,000 including VAT
Framework lot values may be shared with other lots
Contract dates (estimated)
- 1 February 2026 to 31 January 2029
- Possible extension to 31 January 2030
- 4 years
Description of possible extension:
There is an optional 12 month extension. The procurement lead will engage with clinical stakeholders from participating Organisations to determine if the extension option should be utilised. Approval to extend would be sought in line with established NWSSP governance processes
Contract locations
- UKL - Wales
Same for all lots
CPV classifications are shown in the Scope section, because they are the same for all lots.
Lot 3. Patch Pumps
Description
Tubeless Insulin Pumps
Lot value (estimated)
- £7,200,000 excluding VAT
- £8,640,000 including VAT
Framework lot values may be shared with other lots
Contract dates (estimated)
- 1 February 2026 to 31 January 2029
- Possible extension to 31 January 2030
- 4 years
Description of possible extension:
There is an optional 12 month extension. The procurement lead will engage with clinical stakeholders from participating Organisations to determine if the extension option should be utilised. Approval to extend would be sought in line with established NWSSP governance processes
Contract locations
- UKL - Wales
Same for all lots
CPV classifications are shown in the Scope section, because they are the same for all lots.
Lot 4. Data Portals
Description
This Lot relates to stand alone data portals where the data portal provides visibility of data from a range of diabetes tech providers.
Bidders who provide a proprietary data portal i.e. only used with their own diabetes technology will be required to provide details of same within the specific tech lot so should not bid for this lot.
Lot value (estimated)
- £270,244 excluding VAT
- £324,292 including VAT
Framework lot values may be shared with other lots
Contract dates (estimated)
- 1 February 2026 to 31 January 2029
- Possible extension to 31 January 2030
- 4 years
Description of possible extension:
There is an optional 12 month extension. The procurement lead will engage with clinical stakeholders from participating Organisations to determine if the extension option should be utilised. Approval to extend would be sought in line with established NWSSP governance processes
Contract locations
- UKL - Wales
Same for all lots
CPV classifications are shown in the Scope section, because they are the same for all lots.
Lot 5. Smart Insulin Pens
Description
Pens must incorporate technology and be available via the procured route.
Lot value (estimated)
- £200,000 excluding VAT
- £240,000 including VAT
Framework lot values may be shared with other lots
Contract dates (estimated)
- 1 February 2026 to 31 January 2029
- Possible extension to 31 January 2030
- 4 years
Description of possible extension:
There is an optional 12 month extension. The procurement lead will engage with clinical stakeholders from participating Organisations to determine if the extension option should be utilised. Approval to extend would be sought in line with established NWSSP governance processes
Contract locations
- UKL - Wales
Same for all lots
CPV classifications are shown in the Scope section, because they are the same for all lots.
Framework
Maximum number of suppliers
50
Maximum percentage fee charged to suppliers
0%
Justification for framework term over 4 years
NA
Framework operation description
The framework will look to provide national pricing for NHS Wales. Bidders will also have the option to offer banded pricing by Health Board. Direct Award is anticipated to be the preferred method of business award for each participating Organisation. Each participating Organisation has the option of being able to buy directly from the Framework for up to the 4-year period based on the information and product pricing provided by each Bidder. Bidders are able to submit value based proposal as part of the tender submission and should their bid be successful, throughout the life of the contract. The value based proposal will not form part of the tender evaluation.
Award method when using the framework
Without competition
Contracting authorities that may use the framework
Establishing party only
Participation
Legal and financial capacity conditions of participation
Lot 1. Tubed Insulin Pumps
As detailed in the conditions of participation and the ITT
Lot 2. CGM
Lot 3. Patch Pumps
Lot 4. Data Portals
Lot 5. Smart Insulin Pens
As stated in the conditions of participation and the ITT
Technical ability conditions of participation
Lot 1. Tubed Insulin Pumps
Lot 5. Smart Insulin Pens
As detailed in the technical specification included in the ITT
Lot 2. CGM
Lot 3. Patch Pumps
Lot 4. Data Portals
As stated in the ITT
Submission
Enquiry deadline
4 September 2025, 12:00pm
Tender submission deadline
11 September 2025, 12:00pm
Submission address and any special instructions
The tender opportunity will be managed via the eTender Wales Portal https://etenderwales.bravosolution.co.uk/web/login.shtml
All associated documentation will be made available via the website. Bidders should note that late bids will not be accepted. Deadlines are clearly stated within the ITT.
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
9 January 2026
Recurring procurement
Publication date of next tender notice (estimated): 1 June 2030
Award criteria
Lot 1. Tubed Insulin Pumps
Lot 2. CGM
Lot 3. Patch Pumps
Lot 4. Data Portals
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | As per the technical specification detailed in the ITT |
Quality | 60.00% |
| Cost | As per the commercial evaluation criteria stated in the ITT |
Cost | 40.00% |
Lot 5. Smart Insulin Pens
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | Quality criteria as stated in the ITT |
Quality | 60.00% |
| Commercial | As detailed in the Commercial Evaluation criteria included in the ITT |
Cost | 40.00% |
Other information
Payment terms
All information is provided within the ITT document including the e-trading requirements and the NHS Wales No Purchase Order No Pay Policy. The specification includes information relating to Purchase Order and Invoice management.
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
Alder House, Alder Court, St. Asaph Business Park
St. Asaph
LL17 0JL
United Kingdom
Contact name: Melanie Foote-Jones
Region: UKL13 - Conwy and Denbighshire
Organisation type: Public authority - central government
Devolved regulations that apply: Wales